z-logo
open-access-imgOpen Access
Impact of Aldosterone on Vascular Pathophysiology
Author(s) -
Struthers Allan D.
Publication year - 2002
Publication title -
congestive heart failure
Language(s) - English
Resource type - Journals
eISSN - 1751-7133
pISSN - 1527-5299
DOI - 10.1111/j.1527-5299.2002.00722.x
Subject(s) - aldosterone , spironolactone , medicine , heart failure , endothelial dysfunction , cardiology , pathophysiology , nitric oxide , endothelium
The fact that spironolactone reduces deaths in cardiac failure suggests that aldosterone promotes cardiac death in heart failure, which begs the question: What are the mechanisms whereby it does this? The mechanisms whereby aldosterone promotes cardiac death are likely to be a combination of its production of endothelial dysfunction, myocardial fibrosis, and autonomic imbalance. It is quite possible that all three of these mechanisms actually stem from aldosterone's adverse effects on the endothelium. The term “aldosterone vasculopathy” has been coined to describe that the fundamentally adverse effect of aldosterone may well be on endothelial nitric oxide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here